Fibroblast growth factor receptor expression in hemangioblastomas: A novel therapeutic target.
Hemangioblastoma is a highly vascularized, benign tumor in the central nervous system, frequently associated with von Hippel-Lindau (VHL) disease. Hemangioblastoma may cause tumor-associated hemorrhage or exert pressure on nearby structures, leading to life-threatening complications. Although surgic...
Saved in:
| Main Authors: | Maya Puttonen, Olli Tynninen, Sami Salmikangas, Tiina Vesterinen, Harri Sihto, Tom Böhling |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0323979 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intradural extramedullary hemangioblastoma Hemangioblastoma intradural extramedular
by: Everton Barbosa-Silva, et al.
Published: (2009-06-01) -
Pharmacokinetic profile and in vivo anticancer efficacy of anagrelide administered subcutaneously in rodents
by: Kirsi Toivanen, et al.
Published: (2025-12-01) -
Hemangioblastoma de localização supra-tentorial
by: Murilo Côrtes Drummond, et al.
Published: (1977-06-01) -
Hemangioblastoma in the Lung: Metastatic or Primary Lesions?
by: Li Lu, et al.
Published: (2014-01-01) -
Cauda equina hemangioblastoma: case report
by: Leodante Batista da Costa Jr, et al.
Published: (2003-06-01)